Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-5 of 5
Keywords: Hormone-refractory prostate cancer
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Effects of Androgen Ablation Therapy in TRAIL Death Ligand and Its Receptors Expression in Advanced Prostate Cancer
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2010) 84 (4): 445–451.
Published Online: 26 March 2010
... to hormone-sensitive PCa patients. Conclusions: AAT alters TRAIL death ligand and its receptors expression in patients with PCa. 5 08 2009 20 10 2009 26 3 2010 Prostate cancer TRAIL Androgen ablation therapy Hormone-refractory prostate cancer © 2010 S. Karger AG, Basel 2010...
Journal Articles
Docetaxel plus Prednisone versus Mitoxantrone plus Prednisone for Metastatic Hormone-Refractory Prostate Cancer in Chinese Patients: Experience of a Single Center
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2007) 79 (4): 307–311.
Published Online: 22 November 2007
...Hai Liang Zhang; Ding Wei Ye; Xu Dong Yao; Bo Dai; Shi Lin Zhang; Yi Jun Shen; Yao Zhu; Wen Zhang Purpose: To preliminarily investigate the efficacy of docetaxel plus prednisone and mitoxantrone plus prednisone for treating metastatic hormone-refractory prostate cancer and to further evaluate its...
Journal Articles
Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy
Available to PurchaseSubject Area:
Further Areas
Daisaku Hirano, Sadatsugu Minei, Yuichi Kishimoto, Kenya Yamaguchi, Takahiko Hachiya, Toshio Yoshida, Tetsuo Yoshikawa, Makoto Endoh, Yataroh Yamanaka, Tadao Yamamoto, Yasuo Satoh, Hajime Ishida, Kiyoki Okada, Yukie Takimoto
Journal:
Urologia Internationalis
Urol Int (2005) 75 (1): 43–49.
Published Online: 12 July 2005
... cytotoxic agents has been widely used in clinical trials as an anti-tumor agent for the treatment of hormone-refractory prostate cancer (HRPC). However, few prospective studies have considered the efficacy of EMP monotherapy for HRPC patients following androgen-deprivation therapy (ADT), given...
Journal Articles
Prostate-Specific Antigen Levels and Prognosis in Patients with Hormone-Refractory Prostate Cancer Treated with Low-Dose Dexamethasone
Available to PurchaseSubject Area:
Further Areas
Masaaki Morioka, Tatsuya Kobayashi, Yoji Furukawa, Yoshimasa Jo, Masanori Shinkai, Takakazu Matsuki, Tokunori Yamamoto, Hiroyoshi Tanaka
Journal:
Urologia Internationalis
Urol Int (2002) 68 (1): 10–15.
Published Online: 09 January 2002
...Masaaki Morioka; Tatsuya Kobayashi; Yoji Furukawa; Yoshimasa Jo; Masanori Shinkai; Takakazu Matsuki; Tokunori Yamamoto; Hiroyoshi Tanaka Objective: The efficacy of low-dose dexamethasone (DXM) therapy in patients with hormone-refractory prostate cancer (HRPC) was evaluated. Patients and Methods...
Journal Articles
Hormonal Sensitivity following Endocrine Withdrawal in Hormone-Refractory Prostate Cancer
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2000) 65 (1): 28–31.
Published Online: 18 August 2000
... decline following oral endocrine withdrawal may maintain hormonal sensitivity. Hormone-refractory prostate cancer Hormonal sensitivity Prostate-specific antigen Dexamethasone © 2000 S. Karger AG, Basel 2000 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...
